Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy

Michael C. Dyle, Scott M. Ebert, Daniel P. Cook, Steven D. Kunkel, Daniel K. Fox, Kale S. Bongers, Steven A. Bullard, Jason M. Dierdorff, Christopher M. Adams

Research output: Contribution to journalArticlepeer-review


Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.

Original languageEnglish (US)
Pages (from-to)14913-14924
Number of pages12
JournalJournal of Biological Chemistry
Issue number21
StatePublished - 2014

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy'. Together they form a unique fingerprint.

Cite this